Oseltamivir Phosphate For Oral Suspension

Oseltamivir Phosphate For Oral Suspension
SPL v5
SPL
SPL Set ID 7c0923ad-80b0-4134-b44a-754ea599f356
Route
ORAL
Published
Effective Date 2024-07-30
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Oseltamivir Acid (6 mg)
Inactive Ingredients
Monosodium Citrate Saccharin Sodium Sodium Benzoate Sorbitol Titanium Dioxide Water Xanthan Gum

Identifiers & Packaging

Pill Appearance
Color: white
Marketing Status
ANDA Active Since 2021-08-05

Description

NDC 70771-1598-6 Oseltamivir Phosphate for Oral Suspension 6 mg/mL * 60 mL (usable volume after constitution)


Medication Information

Description

NDC 70771-1598-6 Oseltamivir Phosphate for Oral Suspension 6 mg/mL * 60 mL (usable volume after constitution)

Package Label.principal Display Panel

NDC 70771-1598-6

Oseltamivir Phosphate for Oral Suspension

6 mg/mL *

60 mL (usable volume after constitution)


Structured Label Content

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

NDC 70771-1598-6

Oseltamivir Phosphate for Oral Suspension

6 mg/mL *

60 mL (usable volume after constitution)


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)